Shreerang Bhide

5.7k total citations · 1 hit paper
96 papers, 3.8k citations indexed

About

Shreerang Bhide is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Shreerang Bhide has authored 96 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Otorhinolaryngology, 29 papers in Surgery and 26 papers in Oncology. Recurrent topics in Shreerang Bhide's work include Head and Neck Cancer Studies (59 papers), Advanced Radiotherapy Techniques (17 papers) and Head and Neck Surgical Oncology (14 papers). Shreerang Bhide is often cited by papers focused on Head and Neck Cancer Studies (59 papers), Advanced Radiotherapy Techniques (17 papers) and Head and Neck Surgical Oncology (14 papers). Shreerang Bhide collaborates with scholars based in United Kingdom, United States and India. Shreerang Bhide's co-authors include Kevin J. Harrington, Christopher M. Nutting, Kate Newbold, Aisha Miah, Catharine H. Clark, Mary Anne Tanay, Teresa Guerrero Urbano, James P. Morden, Elizabeth Miles and Emma Hall and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Shreerang Bhide

94 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial

2011 1.2k citations Christopher M. Nutting, James P. Morden et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Shreerang Bhide

Since Specialization

Citations

This map shows the geographic impact of Shreerang Bhide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shreerang Bhide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shreerang Bhide more than expected).

Fields of papers citing papers by Shreerang Bhide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shreerang Bhide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shreerang Bhide. The network helps show where Shreerang Bhide may publish in the future.

Co-authorship network of co-authors of Shreerang Bhide

This figure shows the co-authorship network connecting the top 25 collaborators of Shreerang Bhide. A scholar is included among the top collaborators of Shreerang Bhide based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shreerang Bhide. Shreerang Bhide is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A systematic review of antibody-drug conjugates and bispecific antibodies in head and neck squamous cell carcinoma and nasopharyngeal carcinoma: Charting the course of future therapies 2024 ·Cancer Treatment Reviews ·(unknown), Antonio Rullan, (unknown), (unknown), Shreerang Bhide, Ben O’Leary, Irene Braña, Kevin J. Harrington	10
2	FUME-TCRseq Enables Sensitive and Accurate Sequencing of the T-cell Receptor from Limited Input of Degraded RNA 2024 ·Cancer Research ·Ann‐Marie Baker, (unknown), Pablo Nenclares, Tahel Ronel, (unknown), Christopher Kimberley, Miangela M. Laclé, Shreerang Bhide, Kevin J. Harrington, Alan Melcher, Manuel Rodriguez‐Justo, Benny Chain, Trevor A. Graham	3
3	Circulating HPV DNA as a Biomarker for Pre-Invasive and Early Invasive Cervical Cancer: A Feasibility Study 2023 ·Cancers ·(unknown), (unknown), Richard Gunu, Allison Jones, Adeola Olaitan, Adam N. Rosenthal, Ros Cutts, Isaac García-Murillas, Nicholas C. Turner, Susan Lalondrelle, Shreerang Bhide	7
4	Systematic review and meta-analysis of occult contralateral nodal metastases in patients with oropharyngeal squamous carcinoma undergoing elective neck dissection 2022 ·European Journal of Surgical Oncology ·Akshat Malik, John Hardman, (unknown), Christopher M. Nutting, Shreerang Bhide, Kevin J. Harrington, Clare Schilling, Vinidh Paleri	2
5	On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy 2021 ·Journal for ImmunoTherapy of Cancer ·Pablo Nenclares, (unknown), (unknown), (unknown), (unknown), Isla Leslie, Kee H. Wong, Alan Melcher, Kate Newbold, Chris Nutting, Derfel ap Dafydd, Shreerang Bhide, Kevin J. Harrington	29
6	Imaging predictors of treatment outcomes in rectal cancer: An overview 2018 ·Critical Reviews in Oncology/Hematology ·Lakshmi Shree Kulumani Mahadevan, Jim Zhong, Bhanu Prasad Venkatesulu, Harmeet Kaur, Shreerang Bhide, Bruce D. Minsky, William Chu, Martijn Intven, Uulke A. van der Heide, Baukelien van Triest, Sunil Krishnan, William A. Hall	17
7	Intensity modulated radiotherapy in locally advanced thyroid cancer: Outcomes of a sequential phase I dose-escalation study 2018 ·Radiotherapy and Oncology ·Keith Rooney, Aisha Miah, Shreerang Bhide, Teresa Guerrero Urbano, Mansour T. A. Sharabiani, Kate Newbold, Lorna Grove, Kevin J. Harrington, Christopher M. Nutting	3
8	Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI 2017 ·Clinical Cancer Research ·Rafał Panek, Liam Welsh, (unknown), Maria A. Schmidt, Kee H. Wong, Angela M. Riddell, Dow‐Mu Koh, Alex Dunlop, Dualta Mcquaid, James A. d’Arcy, Shreerang Bhide, Kevin J. Harrington, Christopher M. Nutting, (unknown), Cheryl Richardson, Carol Box, Suzanne A. Eccles, Martin O. Leach, Simon P. Robinson, Kate Newbold	32
9	Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy 2017 ·Clinical and Translational Radiation Oncology ·Jamie Dean, Kee H. Wong, Hiram A. Gay, Liam Welsh, (unknown), (unknown), Jung Hun Oh, Aditya Apte, Kate Newbold, Shreerang Bhide, Kevin J. Harrington, Joseph O. Deasy, Christopher M. Nutting, S. Gulliford	29
10	Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma 2017 ·British Journal of Cancer ·(unknown), Isaac García-Murillas, Rosalind Cutts, David González de Castro, Lorna Grove, (unknown), Fuqiang Wang, Christopher M. Nutting, K. Newbold, Kevin J. Harrington, Nicholas C. Turner, Shreerang Bhide	103
11	CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy 2016 ·Molecular Cancer Therapeutics ·Holly E. Barker, Radhika Patel, Martin McLaughlin, Ulrike Schick, Shane Zaidi, Christopher M. Nutting, K. Newbold, Shreerang Bhide, Kevin J. Harrington	40
12	Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei 2016 ·Molecular Cancer Therapeutics ·Magnus T. Dillon, Holly E. Barker, Malin Pedersen, Hind Hafsi, Shreerang Bhide, Kate Newbold, Christopher M. Nutting, Martin McLaughlin, Kevin J. Harrington	82
13	Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Jamie Dean, Kee H. Wong, Hiram A. Gay, Liam Welsh, (unknown), Ulrike Schick, Jung Hun Oh, Aditya Apte, Kate Newbold, Shreerang Bhide, Kevin J. Harrington, Joseph O. Deasy, Christopher M. Nutting, S. Gulliford	17
14	Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions 2015 ·International Journal of Radiation OncologyBiologyPhysics ·Sophie Otter, Ulrike Schick, S. Gulliford, Punita Lal, Davide Franceschini, K. Newbold, Christopher M. Nutting, Kevin J. Harrington, Shreerang Bhide	33
15	Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway 2012 ·BMC Cancer ·Katie Twigger, Victoria Roulstone, Joan Kyula, Eleni Karapanagiotou, Konstantinos N. Syrigos, Richard Morgan, Christine L. White, Shreerang Bhide, Gerard J. Nuovo, Matt Coffey, Brad Thompson, Adel Jebar, Fiona Errington‐Mais, Alan Melcher, Richard G. Vile, Hardev Pandha, Kevin J. Harrington	46
16	Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial breakdown → 2011 ·The Lancet Oncology ·Christopher M. Nutting, James P. Morden, Kevin J. Harrington, Teresa Guerrero Urbano, Shreerang Bhide, Catharine H. Clark, Elizabeth Miles, Aisha Miah, Kate Newbold, Mary Anne Tanay, F. Adab, Sarah Jefferies, Christopher Scrase, B. Yap, Roger A’Hern, Mark Sydenham, Marie A. Emson, Emma Hall	1202
17	Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck 2010 ·Clinical Cancer Research ·Kevin J. Harrington, Mohan Hingorani, Mary Anne Tanay, Jennifer Hickey, Shreerang Bhide, Peter Clarke, (unknown), Khin Thway, Amen Sibtain, Iain A. McNeish, Kate Newbold, Howard Goldsweig, Robert S. Coffin, Christopher M. Nutting	216
18	External Beam Radiotherapy for Differentiated Thyroid Cancer 2010 ·Clinical Oncology ·Ceri Powell, Kate Newbold, Kevin J. Harrington, Shreerang Bhide, Christopher M. Nutting	10
19	Enhanced In vitro and In vivo Cytotoxicity of Combined Reovirus and Radiotherapy 2008 ·Clinical Cancer Research ·Katie Twigger, Laura Vidal, Christine L. White, Johann S. de Bono, Shreerang Bhide, Matt Coffey, Brad Thompson, Richard G. Vile, Lucy Heinemann, Hardev Pandha, Fiona Errington‐Mais, Alan Melcher, Kevin J. Harrington	88
20	Otological Toxicity After Postoperative Radiotherapy for Parotid Tumours 2006 ·Clinical Oncology ·Shreerang Bhide, Kevin J. Harrington, Christopher M. Nutting	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact